We are live on
!
Find out more
AC
Almitas Capital Portfolio holdings
AUM
$443M
1-Year Est. Return
42.36%
This Fund
S&P 500
This Quarter
Est. Return
+0.05%
1 Year Est. Return
+42.36%
3 Year Est. Return
+85.86%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$241M
AUM Growth
-$1.57M
(-0.65%)
Cap. Flow
-$5.89M
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
52.29%
Holding
92
New
23
Increased
25
Reduced
21
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackRock Health Sciences Trust II
BMEZ
|
+$12.6M |
| 2 |
BlackRock ESG Capital Allocation Term Trust
ECAT
|
+$6.53M |
| 3 |
Atea Pharmaceuticals
AVIR
|
+$4.81M |
| 4 |
MMD
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
|
+$4.49M |
| 5 |
JPI
Nuveen Preferred Securities & Income Opportunities Fund
JPI
|
+$4.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AJXA
Great Ajax Corp.7.25% Convertible Senior Notes due 2024
AJXA
|
+$22.3M |
| 2 |
FIF
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
|
+$7.58M |
| 3 |
FEN
First Trust Energy Income and Growth Fund
FEN
|
+$6.33M |
| 4 |
PDX
PIMCO Dynamic Income Strategy Fund
PDX
|
+$5.77M |
| 5 |
KTF
DWS Municipal Income Trust
KTF
|
+$3.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.33% |
| 2 | Financials | 4.08% |
| 3 | Real Estate | 1.13% |
Similar funds
HBT
EFMC
CMAI
BFA
GWM
CP
CMP
PLU
Almitas Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Almitas Capital held 92 positions worth $241M, down 0.65% from $242M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Almitas Capital's Q2 2024 filing shows 23 new, 25 increased, 21 reduced and 16 closed positions. Its largest new stake was Atea Pharmaceuticals: 1,290,187 shares worth $4.27M. The largest sale was Great Ajax Corp.7.25% Convertible Senior Notes due 2024, an estimated $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, up from 2.1% a quarter earlier, followed by Financials and Real Estate.
- Almitas Capital's largest Q2 2024 buy was Atea Pharmaceuticals: 1,290,187 shares worth $4.27M.
- Almitas Capital added most to BlackRock Health Sciences Trust II in Q2 2024, an estimated $12.6M increase.
- Almitas Capital's biggest Q2 2024 reduction was PIMCO Dynamic Income Strategy Fund, cutting an estimated $5.77M.
- Almitas Capital fully exited Great Ajax Corp.7.25% Convertible Senior Notes due 2024 in Q2 2024, selling an estimated $22.3M.
- Almitas Capital's ten largest holdings make up 52% of its $241M portfolio in Q2 2024.
- Almitas Capital opened 23 new positions and closed 16 in Q2 2024.
- Almitas Capital's portfolio value fell 0.65% quarter-over-quarter to $241M.
Based on Almitas Capital's 13F filing for Q2 2024, filed 15 Aug 2024.